Cargando…
Relaxin Family Member Insulin‐Like Peptide 6 Ameliorates Cardiac Fibrosis and Prevents Cardiac Remodeling in Murine Heart Failure Models
BACKGROUND: The insulin/insulin‐like growth factor/relaxin family represents a group of structurally related but functionally diverse proteins. The family member relaxin‐2 has been evaluated in clinical trials for its efficacy in the treatment of acute heart failure. In this study, we assessed the r...
Autores principales: | Maruyama, Sonomi, Wu, Chia‐Ling, Yoshida, Sumiko, Zhang, Dongying, Li, Pei‐Hsuan, Wu, Fangzhou, Parker Duffen, Jennifer, Yao, Rouan, Jardin, Blake, Adham, Ibrahim M., Law, Ronald, Berger, Joel, Di Marchi, Richard, Walsh, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220528/ https://www.ncbi.nlm.nih.gov/pubmed/29887522 http://dx.doi.org/10.1161/JAHA.117.008441 |
Ejemplares similares
-
The injury-induced myokine insulin-like 6 is protective in experimental autoimmune myositis
por: Zeng, Ling, et al.
Publicado: (2014) -
Characterizing relaxin receptor expression and exploring relaxin’s effect on tissue remodeling/fibrosis in the human bladder
por: Diaz, Edward C., et al.
Publicado: (2020) -
Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway
por: Zhou, X, et al.
Publicado: (2015) -
Relaxin'
Publicado: (1983) -
Relaxin
por: DeCherney, Alan H.
Publicado: (1982)